Macro Biologics, Inc.
Macro Biologics, Inc. is dedicated to designing, patenting, and producing macro biologics, which are large molecule biologics with both physical properties and functional activities. These biologics are composed of natural building blocks, such as amino acids or carbohydrates, and are designed to degrade back into their natural components, making them environmentally friendly. The company aims to address significant global challenges, such as antibiotic resistance and pollution, by providing biologics that are safe for both people and the environment. Macro Biologics is committed to the highest standards of science, medicine, and business, with a focus on healthcare applications.
Macro Biologics, Inc.
3142 Tiger Run Court - Suite 101, Carlsbad, California 92010
What We Do
Large molecule biologics with physical properties and functional activities, composed of natural building blocks that degrade back into their natural components.
Proprietary macro biologics designed for local application to prevent and treat life-threatening infections, combining barrier formation with broad microbicidal activity.
An investigational product designed for direct application by surgeons to exposed tissues, intended to prevent life-threatening infections following surgery.
Designed for military use in prolonged field settings, this product treats contamination and prevents infection for up to 72 hours.
An investigational product for direct application to contaminated and infected tissues, combining surfactant activity with broad microbicidal activity.
Developed to prevent and treat infections in emergency settings, maintaining surfactant and microbicidal dual mode of action.
Application Area
Show LessInfectious Diseases
Key People
CEO, CSO, Director & Co-Founder
Head of SAB & Co-Founder
Vice President of Operations
Director of Preclinical Development
Associate Director of Materials Science
Associate Director of Corporate Dev.
News & Updates
Macro Biologics partners with Beiersdorf to develop antimicrobial peptides.
Macro Biologics to present at the World AMR Congress 2024.
Amicrobe changes its name to Macro Biologics.